1 - IBM (information-based medicine) versus EBM (evidence-based medicine): Implications for faculty and trainees

Friday, April 28, 2023

3:45 PM – 4:00 PM ET

Location: Convention Center: 159 AB

SIG Speaker(s)

Robert M. Jacobson, M.D. (he/him/his)
Professor of Pediatrics
Mayo Clinic College of Medicine and Science
Rochester, Minnesota, United States

Disclosure(s):

Robert M. Jacobson, MD: Abbott Laboratories: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds (Ongoing); AbbVie Company: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds (Ongoing); Becton Dickinson & Co: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds (Ongoing); Eli Lilly & Company: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds (Ongoing); Johnson & Johnson: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds (Ongoing); Merck & Co., Inc.: Contractor including contracted research (Ongoing); Moderna, Inc.: Research Support including clinical trials & the principal or named investigator (Ongoing); Takeda Pharma Co.: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds (Ongoing)